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Abstract The ESX (or Type VII) secretion systems are protein export systems in mycobacteria
and many Gram-positive bacteria that mediate a broad range of functions including virulence,
conjugation, and metabolic regulation. These systems translocate folded dimers of WXG100-
superfamily protein substrates across the cytoplasmic membrane. We report the cryo-electron
microscopy structure of an ESX-3 system, purified using an epitope tag inserted with
recombineering into the chromosome of the model organism Mycobacterium smegmatis. The
structure reveals a stacked architecture that extends above and below the inner membrane of the
bacterium. The ESX-3 protomer complex is assembled from a single copy of the EccB3, EccC3, and
EccE3 and two copies of the EccD3 protein. In the structure, the protomers form a stable dimer
that is consistent with assembly into a larger oligomer. The ESX-3 structure provides a framework
for further study of these important bacterial transporters.
Introduction
Mycobacteria use a set of specialized secretion systems called ESX to transport proteins across their
complex, diderm cell walls (Gro¨schel et al., 2016). Originally described as virulence factors in Myco-
bacteria tuberculosis (Guinn et al., 2004; Hsu et al., 2003; Lewis et al., 2003; Stanley et al.,
2003), orthologs of ESX have since been discovered in most Gram-positive bacteria (Bottai et al.,
2017), and are more generally referred to as Type VII secretion systems (Bitter et al., 2009). In
mycobacteria there are five paralogous ESX operons (ESX 1–5) each of which encodes an inner mem-
brane translocon complex consisting of three conserved Ecc proteins: EccB, EccC, and EccD. A
fourth protein, EccE is conserved in all ESX operons except the ancestral ESX-4 operon and is also
considered a part of the ESX translocon complex as it copurifies with EccB, EccC, and EccD
(Houben et al., 2012). All Type VII secretion systems translocate proteins in the WXG100-superfam-
ily, which share a common two-helix hairpin structure and are found as homo- or heterodimers
(Poulsen et al., 2014) and are mutually dependent for secretion with other substrates
(Fortune et al., 2005). In contrast to the general secretory apparatus (Sec), ESX substrates have
been shown to be secreted in their folded, dimeric state (Sysoeva et al., 2014).
Structural and functional information has been reported for truncated and isolated, soluble
domains of the ESX translocon complexes and their homologs (Korotkova et al., 2015;
Korotkova et al., 2014; Renshaw et al., 2005; Rosenberg et al., 2015; Strong et al., 2006;
Wagner et al., 2016; Wagner et al., 2014; Wagner et al., 2013; Zhang et al., 2015; Zoltner et al.,
2016). A low resolution, negative stain electron microscopy structure of ESX-5 shows a translocon
complex assembled into a hexamer (Beckham et al., 2017). Structures of other proteins encoded in
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ESX operons including secreted substrates (Ilghari et al., 2011), substrate chaperons (Ekiert and
Cox, 2014), and the protease MycP (Solomonson et al., 2013) have been solved. Despite revealing
important functional information about ESX, structures of overexpressed and isolated proteins are
insufficient to understand the regulated secretion of fully folded substrates. We therefore undertook
structural studies of an endogenously expressed ESX-3 complex from the model organism M. smeg-
matis using cryo-electron microscopy (cryo-EM). During the preparation of this work for publication,
a similar structure of the ESX-3 system expressed from a plasmid was published by another group
(Famelis et al., 2019).
The ESX-3 translocon complex is important for iron acquisition (Serafini et al., 2013;
Siegrist et al., 2009), cell survival (Tinaztepe et al., 2016), and virulence in pathogenic mycobacte-
ria (Tufariello et al., 2016), and its role in iron homeostasis is conserved in the model system, M.
smegmatis (Siegrist et al., 2009). The ESX-3 translocon complex proteins are transcribed in a single
operon (Li et al., 2017), and expression of the ESX-3 operon is dependent on the transcriptional
regulator IdeR, which controls iron metabolism (Rodriguez et al., 2002) and is required for growth
in the human pathogen M. tuberculosis (Pandey and Rodriguez, 2014). The ESX-3 operon is 67%
identical between the non-pathogenic model organism M. smegmatis and the pathogen M. tubercu-
losis over the 4354 amino acids of the ESX-3 operon. This high degree of conservation and essential
role in cell growth makes ESX-3 an important candidate for small molecule inhibition (Bottai et al.,
2014), as blockade of ESX-3 will both inhibit virulence in M. tuberculosis and kill a broad range of
pathogenic mycobacteria.
Results
A major innovation made possible by the dramatic improvements in cryo-EM (Cheng, 2018) is the
ability to examine challenging protein samples at atomic resolution, even when samples are only
available at low concentrations. When coupled with recent genetic manipulations that allow for facile
insertion of chromosomal epitope and purification tags (Murphy et al., 2018), cryo-EM now holds
the promise of routine structural characterization of many endogenously expressed protein com-
plexes not previously tractable by structural techniques. We undertook the purification of the ESX-3
complex from the native host without the need for overexpression. To facilitate purification of the
endogenous translocon complex, a cleavable EGFP tag was inserted into the chromosome of M.
smegmatis mc(2)155 (wild type) and DideR (Dussurget et al., 1996) strains at the C-terminus of
EccE3 via the ORBIT method (Murphy et al., 2018) (Figure 1A, Figure 1—figure supplement 1).
EccE3 is the final gene in the 11 gene long ESX-3 operon making insertion at this site less likely to
disrupt regulation and expression of the operon. Deletion of the gene for the iron acquisition regula-
tor IdeR greatly increases chromosomal expression of ESX-3 from negligible amounts of protein to a
yield sufficient for purification and structure determination (Figure 1—figure supplement 2A). Com-
ponents of ESX-3 were pulled down using an anti-GFP nanobody (Rothbauer et al., 2008) and the
EGFP tag was proteolytically cleaved. After size exclusion chromatography, the peak fractions were
pooled and analyzed biochemically and by cryo-EM .
Global structure of the ESX-3 dimer
Four components of the ESX-3 translocon complex EccB3, EccC3, EccD3 and EccE3 were stably affin-
ity-purified as a large molecular weight species of about 900 kDa (Figure 1B and C, Figure 1—fig-
ure supplement 2B). The sample was imaged by cryo-EM and reconstructed revealing a dimeric
structure, which can be divided into four areas: the flexible periplasmic multimerization domain, the
stable transmembrane region, the stable upper cytoplasmic region, and the flexible lower cyto-
plasmic motor domain (Figure 1D, Table 1). While the peak fraction does not contain particles of a
larger size consistent with higher order oligomers, thorough examination of the void volume
revealed a small number of particles in a higher oligomeric state (Figure 1—figure supplement 3A–
E). The resolution of the ESX-3 dimer varies substantially in different parts of the electron microscopy
map and this heterogeneity was partially resolved through data processing (Figure 1—figure sup-
plement 4 and Figure 1—figure supplement 5). Initially, the entire ESX-3 dimer was reconstructed
to 4.0 A˚ resolution (Figure 1—figure supplement 6A). Using symmetry expansion, and focused clas-
sification and refinement techniques, the resolutions of targeted regions of the ESX-3 complex were
improved to 3.7 A˚ for the transmembrane region and upper cytoplasmic region (Figure 1—figure
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Figure 1. Overview of the ESX-3 tagging, purification, and structure. (A) The ESX-3 operon in M. smegmatis and the placement of the purification tag.
Genomic deletion of ideR derepresses ESX-3 to boost expression for purification. (B) SDS-PAGE of purified ESX-3 shows four major bands
corresponding to EccB3, EccC3, EccD3, and EccE3. (C) Blue native page of the purified ESX-3 complex shows a large molecular weight band around 900
kDa. (D) Merged maps of all focused refinement maps (gray transparency) of the ESX-3 dimer filtered to 10 A˚ resolution. The transmembrane and
upper cytoplasmic focused maps (3.7 A˚) are segmented by subunit showing one copy per protomer of EccB3 (pink), EccC3 (blue), EccE3 (orange),
EccD3-bent (yellow), and EccD3-extended (green). (E) Atomic models of the transmembrane and upper cytoplasmic regions. (F) A combined map of the full
complex filtered to 10 A˚ resolution (gray transparency) with full models for each protein, EccD3-bent (yellow), EccD3-extended (green), EccE3 (orange),
EccC3 (blue), and EccB3 (pink).
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. ORBIT tagging of the chromosomal copy of EccE3.
Figure supplement 2. ESX-3 dimer purification optimization.
Figure 1 continued on next page
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supplement 6B–D), 5.8 A˚ for the periplasmic region (Figure 1—figure supplement 6E), and ~7 A˚
resolution for the lower cytoplasmic region (Figure 1—figure supplement 6F). The highest resolu-
tion maps for each region were combined and filtered to the threshold of the lowest resolution map
to form an overall 10 A˚ combination map for the entire ESX-3 dimer.
The ESX-3 dimer is comprised of ten total proteins, two copies each of EccB3, EccC3, and EccE3
and four copies of EccD3. Two pseudo-symmetric protomers referred to as i and ii, combine to form
the ESX-3 dimer. Each protomer contains one copy of EccB3, EccC3, and EccE3 and two conforma-
tionally distinct copies of EccD3, referred to as EccD3-bent and EccD3-extended (Figure 1E) based on
their highly asymmetric conformations. At 3.7 A˚ resolution, it was possible to build de novo atomic
models for all observable amino acids in the transmembrane and upper cytoplasmic regions, except
the two transmembrane helices of EccC3 (Figure 1E and Supplementary file 1). The lower
Figure 1 continued
Figure supplement 3. Examination of the void volume.
Figure supplement 4. Initial data collection and initial model generation.
Figure supplement 5. Data processing workflow for final data collection.
Figure supplement 6. Consensus and focused refinements.
Table 1. Data collection and refinement statistics.
Collection parameters for initial test data set and void peak analysis on the Talos Arctica and final collection on Titan Krios micro-
scopes. Refinement details for initial model, consensus map, and focused refinements.
Data Collection
Collection Initial Screening Collection 1 Collection 2 Void peak
Microscope Talos Arctica Titan Krios Titan Krios Talos Arctica
Voltage (kV) 200 300 300 200
Detector Gatan K2 Gatan K2 Gatan K2 Gatan K3
Pixel size (A˚/pixel) 1.14 0.82 0.82 0.9
Exposure Time (s) 9 10 10 11.7
Electron dose (e-/A˚2) 63 80 67 58
Defocus range (mm) 1.5-2.5 0.4-1.2 0.6-1.4 1.5-2.5
Number of micrographs 2,499 2,705 4,632 1,215
Consensus Reconstruction
Data Set Initial Screening Collection 1 & 2 Void peak
Software Relion 2.1, cisTEM, and cryosparc Relion 3.0 cisTEM
# of particles, picked 240,000 778,149 259,333
# of particles post, Class2D 138,000 554,901 640
# of particles post, Class3D 46,830 362,438 NA
# of particles post, skip align Class3D NA 90,479 NA
Symmetry C1 C1 NA
Map sharpening B-factor (A˚2) NA -160 NA
Final resolution (A˚) 4.7 A˚ 4.0 A˚ NA
Focused Refinements
Location of focus # of particles Resolution
Protomer i 76,967 3.8
Protomer ii 90,479 3.8
Symmetry expanded protomer 52,067 3.7
Periplasmic EccB3 70,000 5.8
ATPase 1, 2, and 3 30,000 7
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resolution regions of density, the EccC3 transmembrane helices, EccC3 ATPase 1, 2, and 3 domains
and the EccB3 periplasmic domain, were flexibly fit using homology models. Using this hybrid
approach, a model of the entire ESX-3 dimer has been produced (Figure 1F).
EccD3 forms a homodimer that encloses a large hydrophobic cavity
There are two copies of EccD3 in each ESX-3 protomer (Figure 2A). The ubiquitin-like N-terminal
domain of each EccD3 molecule interacts with EccE3 and EccC3 in the cytoplasm, and a long linker
joins the soluble domain of EccD3 to 11 transmembrane helices (Figure 2B and Figure 2—figure
supplement 1A–F). The four EccD3 molecules account for 44 of the total 54 transmembrane helices
observed in the ESX-3 dimer. A distinct transmembrane cavity is formed by dimerization of the two
copies of EccD3 in each protomer with a cross-sectional diameter of ~2030 A˚ without significant
regions of constriction. Transmembrane helices 1, 9 and 10 interact across the cavity dimer interface
in a tight bundle making passive lipid transport into the membrane from the cavity unlikely
(Figure 2C). The inner surface of the periplasmic half of the cavity is composed primarily of hydro-
phobic residues and in our maps, eight extended densities consistent with hydrophobic lipid tails or
detergent molecules line the periplasmic inner face of the cavity (Figure 2C). In contrast, the
A B
EccD
extendedEccDbent
EccDbent
EccD
extended
Protomer i Protomer ii
Protomer i Protomer ii
C Ordered hydrophobic tails
EccDbent
100
127
127
D
EccDbent
EccD
extended
85°
EccDbent
EccD
extended
EccD
extended
90°
90°
TM10
TM9
TM1
Figure 2. The structure of EccD3. (A) EccD3-bent (yellow) and EccD3-extended (green) in the context of the overall ESX-3 dimer (gray transparency). (B)
Atomic models of EccD3-bent and EccD3-extended (C) An unsharpened electron microscopy density map of the ESX-3 dimer shows extra densities
consistent with lipid or detergent molecules (teal) on the periplasmic face of the EccD3 cavity. (D) EccD3-bent (yellow) and EccD3-extended (green) aligned
based on the transmembrane regions shows two distinct conformations of the EccD3 cytoplasmic domains. Amino acids 100–127 of EccD3 adopt a bent
(yellow) and an extended (green) conformation.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. EccD3 map and model.
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cytoplasmic face of the cavity has several polar residues and ordered hydrophobic densities are not
visible.
In the cytoplasm below the membrane, a stable, upper cytoplasmic region is formed by interac-
tions between the soluble domains of EccD3-bent, EccD3-extended, EccE3, and EccC3. The linker joining
the cytoplasmic ubiquitin-like domain to transmembrane helix 1 (residues 100–127) of EccD3 con-
serves a high sequence identity throughout evolution (Ashkenazy et al., 2016), yet it adopts two
distinct secondary structures resulting in the asymmetric placement of the cytoplasmic domains of
EccD3 (Figure 2D and Figure 2—figure supplement 1A–G). In EccD3-bent, residues 100–127 are
bent, folding into an a-helix and forming a nexus of stabilizing contacts with EccB3 and EccC3 (Fig-
ure 2—figure supplement 1H). In EccD3-extended, residues 100–127 are extended and fold into a
shorter a-helix that interacts with EccE3 and the cytoplasmic domain of EccD3-bent (Figure 2—figure
supplement 1I). This conformational flexibility suggests that if residues 100–127 were released from
their associations with EccC3 and EccE3 they could rearrange into the alternative bent or extended
conformation with little energetic barrier.
EccC3 and EccE3 make extensive, stabilizing interactions with the
asymmetric, cytoplasmic domains of EccD3
The next component of the stable upper cytoplasmic region is EccE3. EccE3 is positioned at the front
of the ESX-3 dimer (Figure 3A), where the conserved transmembrane helix 1 of EccE3 interacts with
helix 11 of EccD3-bent in the membrane. Helix 1 is followed by a second EccE3 transmembrane helix,
a linker helix, and then extends into the cytoplasm (Figure 3B and C and Figure 3—figure supple-
ment 1A–D). The anti-parallel b-sheets of the cytoplasmic domain of EccE3 have weak structural
homology to glycosyl transferase proteins, however, the nucleotide binding pocket is absent in
EccE3, leaving it incapable of performing this function (Figure 3—figure supplement 1E and F,
Supplementary file 2). EccE3 does not have another obvious ligand or catalytic site. Two conserved
helices in the cytoplasmic region of EccE3 between amino acids 133 and 163 form extensive stabiliz-
ing interactions with both subunits of EccD3 (Figure 3D, Figure 3—figure supplement 1G). These
interactions hold the flexible linker of EccD3-extended in the extended conformation and sterically hin-
der EccD3-extended from assuming the bent conformation (Figure 3—figure supplement 1H). EccE3
does not form direct protein-protein interactions with either EccB3 or EccC3 suggesting the contacts
with EccD3-extended and EccD3-bent are extremely stable as EccE3 was the tagged protein used to
immunoprecipitate the ESX-3 dimer.
The final component of the stable upper cytoplasmic region is the domain of unknown function
(DUF) of EccC3. EccC3 extends from the membrane into the upper and lower cytoplasmic regions
(Figure 4A). Amino acids 1–33 and 94–403 of EccC3 were built de novo into the higher resolution
region of the electron microscopy map revealing the structure of the DUF domain (Figure 4B, Fig-
ure 4—figure supplement 1A–C). The de novo model of the DUF has the typical Rossman fold of a
nucleotide hydrolysis domain (Figure 4—figure supplement 1D and E) and its closest homolog by
Dali search is the ATPase 1 domain of EccC of T. curvata. It is linked to the transmembrane domains
by a long helical bundle making extensive contacts with the flexible linker region of EccD3-bent
(Figure 4C). The DUF makes additional stabilizing contacts with the ubiquitin-like domains of EccD3-
bent and EccD3-extended in the cytoplasm (Figure 4D).
When the transmembrane and upper cytoplasmic regions are compared between protomers,
only the transmembrane helices of EccC3 and the N-terminal tail of EccB3 differ (Figure 4—figure
supplement 2A and B), otherwise the protomers are superimposable. All four EccC3 transmembrane
helices were modeled at 6 A˚ resolution through a combination of homology modeling and molecular
dynamics. In protomer i, transmembrane helix 2 forms lipid mediated hydrophobic interactions with
the transmembrane helix of EccB3 in protomer i, and transmembrane helix 1 interacts with trans-
membrane helix 2 of EccC3 in protomer ii. Transmembrane helix 1 of EccC3 in protomer ii is shifted
relative to the protomer i conformation and does not directly interact with other proteins.
The EccC3 motor domains are flexible and asymmetric across the dimer
The motor domains containing the EccC3 ATPase 1, 2 and 3 hang below the DUF domain in the flex-
ible lower cytoplasmic region. They were resolved at a lower resolution than the upper cytoplasmic
domain, but they are clearly asymmetric between protomers i and ii (Figure 4A). Although the
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EccC3 ATPase 1 domains in both protomers are in a similar location relative to the DUF, the ATPase
2 and 3 domains do not superimpose across protomers even at low resolution (Figure 4—figure
supplement 2C) suggesting significant asymmetry between these domains. In protomer i, a homol-
ogy model based on existing EccC structures fits well into the density; however in protomer ii, the
interface between ATPase 1 and 2 is broken relative to the crystal structure with ATPase 2 and
ATPase 3 rotated away from the crystal structure interface.
EccB3 extends into the periplasm and stabilizes dimer formation
The ESX-3 dimer is stabilized by cross-protomer interactions formed by the two EccB3 proteins.
EccB3 begins in the cytoplasm with a flexible N-terminal tail leading into a linker helix, followed by a
single-pass transmembrane helix, and an extended periplasmic domain (Figure 5A and B, Figure 5—
figure supplement 1A and B). The N-terminal tail of EccB3 from protomer i forms extensive cross-
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90°
Figure 3. The structure and protein-protein interactions of EccE3. (A) The placement of EccE3 in the overall ESX-3 dimer. (B) Atomic model of EccE3 (C)
Transmembrane helix 1 of EccE3 interacts with transmembrane helix 11 of EccD3-bent (D) Two soluble helices of EccE3 interact with EccD3-extended and
EccD3-bent.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. EccE3 map and model.
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protomer contacts with EccB3, EccC3, EccD3-bent and EccD3-extended from protomer ii (Figure 5C,
Supplementary file 3). The linker helix of EccB3 forms further protein-protein interactions with
EccC3 and EccD3-bent. The transmembrane helix of EccB3 interacts with transmembrane helix 11 of
EccD3-extended. Two hydrophobic tails consistent with a lipid or detergent molecules link the trans-
membrane helix of EccB3 to transmembrane helix 2 of EccC3 (Figure 5D). The two EccB3 periplasmic
domains share a large interaction interface across the protomers further stabilizing dimerization.
Homology models of two EccB3 proteins can be docked into the periplasmic domain (Figure 5—fig-
ure supplement 1C); however, this region is not resolved sufficiently to identify specific interactions.
The majority of cross-protomer interactions involve EccB3, suggesting the periplasmic domain is
essential for oligomerization.
A hexameric model of ESX-3
Previous reports have shown ESX-1 and ESX-5 form hexamers or higher order multimers
(Beckham et al., 2017; Houben et al., 2012). We modeled a higher order oligomeric state of ESX-3
based on the low-resolution negative stain structure of ESX-5, which had C6 symmetry imposed
EccB
C
B
D
EccC
EccC
EccC
EccC
A
Protomer i Protomer ii
Protomer i Protomer ii
EccB
EccC
EccC
EccD
extendedEccD
extended
EccDfbent
EccDfbent
EccDfbent
EccD
extended
EccC
90°
90°
90°
Figure 4. The structure and protein-protein interactions of EccC3. (A) The placement of EccC3 in the overall ESX-3 dimer. (B) Atomic model of the
EccC3 DUF (C) The stalk helices of EccC3 interact with EccB3, EccD3-bent, and EccD3-extended (D) Interactions between EccC3 and the ubiquitin-like
domains of EccD3-bent and EccD3-extended in the cytoplasm.
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. EccC3 map and model.
Figure supplement 2. Conformational differences between protomer i and protomer ii.
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during refinement (EMDB 3596). The ESX-3 translocon complex was modeled as a trimer of dimers
by low pass filtering the density to 6 A˚ and docking into the ESX-5 negative stain map (Figure 6—
figure supplement 1A). The model of the ESX-3 dimer transmembrane and upper cytoplasmic
regions, including the EccC3 transmembrane helices modeled to 6 A˚ resolution, was fitted into the
trimerically positioned ESX-3 density maps (Figure 6—figure supplement 1B). The angle between
A B
C
Protomer i Protomer ii
EccB
EccB
EccB EccB
EccB
EccB
Protomer i
Protomer ii
D
EccC
TM 1&2
EccD
extended
TM 11
EccB
Ordered hydrophobic tails
90°
Figure 5. The periplasmic multimerization domain. (A) EccB3 (pink) in the context of the overall ESX-3 dimer (gray transparency). EccB3 has a single-
pass transmembrane domain which extends into a large periplasmic domain which was resolved at 5.8 A˚ resolution. (B) Atomic models of the EccB3
cytoplasmic and transmembrane domains, amino acids 14–93 and 32–93. (C) The N-terminus of EccB3 forms extensive cross-protomer contacts with
EccC3 (blue), EccD3-bent (yellow), and EccD3-extended (green). (D) An unsharpened map of the ESX-3 dimer reveals ordered densities consistent with lipids
or detergent molecules mediating the interactions between the EccB3 transmembrane helix (marked with a pink dot) and the EccC3 transmembrane
helices.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. EccB3 maps and models.
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protomers in the trimer of dimers model alternates between 72˚ (the angle between protomers i and
ii in the ESX-3 dimer map) and 48˚ and contains both experimentally observed conformations of
EccC3. The complete model of the ESX-3 translocon complex was docked into the ESX-5 negative
stain map in the same manner revealing major clashes between the low resolution periplasmic and
motor domains in a hexameric form (Figure 6—figure supplement 1C). Accommodation of a hex-
americ complex would require extensive rearrangement of both EccC3 and EccB3.
Discussion
The ESX-3 structure presented here is purified without the addition of substrates or nucleotide. It is
therefore likely to be in a conformation representing the end of the translocation cycle, awaiting
either the direct binding of substrates, the binding of nucleotide or both, to reset a substrate-bind-
ing competent state. By fitting our dimer structure into a prior low resolution envelope we suggest a
model of the oligomeric state of the complex, in close agreement with Famelis et al. However, even
allowing for major rearrangements in the more flexible regions of EccC3 and EccB3, a model built by
the static trimerization of the experimentally determined dimer structure cannot itself explain the
mechanism of action of ESX-3 secretion. The existence of an R-finger catalytic site for ATPase 1 of
EccC3 (Rosenberg et al., 2015) requires the R-finger of one protomer to insert into the active site of
another protomer. Given the ~65 A˚ distance we observe between ATPase 1 domains, the comple-
tion and activation of the catalytic site of ATPase 1 by an R-finger will necessitate an extremely large
rearrangement of the position of the ATPase domains. How might this rearrangement occur? We
propose movements in the highly flexible EccD3 linker lead to the release of EccE3 and EccC3 from
their rigid positions, thus allowing for a rearrangement of the ATPase domains into an active confor-
mation (Figure 6).
Once EccC3 assembles into an oligomeric state, the substrate proteins will need to translocate
through the inner membrane. We have considered two models for how pore formation and transit
might occur: 1) through a pore created by the oligomerization of EccC3 and EccB3 or 2) through the
large cavity created by the dimerization of EccD3. In the first model (Figure 6A), the resting state of
an ESX translocon complex is a hexamer, with disordered EccC3 ATPase domains free in the cytosol,
stabilized by interactions with proteins not seen in the structures presented here (van Winden et al.,
2016). It is possible the rare multi-dimer oligomeric state we see in the void volume, and also seen
by Famelis et al., represents this state. In a hexamer model, the center of the multimer is formed by
the transmembrane helices of EccC3 and EccB3, which create a cavity that could serve as a pore for
translocation of substrates. These transmembrane helices are largely hydrophobic and do not con-
tain obvious residues that would allow for the conductance of hydrated substrates. Thus the produc-
tion of a protein transit channel would require either a large, conformational change in the
transmembrane helices, likely facilitated by movements in the cytoplasmic domains of EccC3, EccD3
and EccE3, or a novel mechanism of action for transit through the central pore.
A hexameric pore created by EccC3 agrees well with the documented mechanism of action for
motor ATPases in the additional strand catalytic E (ASCE) division of P-loop NTPases
(Erzberger and Berger, 2006), which includes EccC3. A hexameric pore also agrees with the pro-
posed mechanism of action for other bacterial secretion systems, such as the Type IV secretion sys-
tem VirD4 coupling protein (Gomis-Ru¨th et al., 2001; Hormaeche et al., 2002), which is related
evolutionarily to EccC3 (Iyer et al., 2004). The hexamer model is thus firmly grounded in the motor
ATPase and bacterial secretion systems literature, although the oligomeric state of VirD4 has
recently been called into question (Redzej et al., 2017) and remains controversial (Llosa and
Alkorta, 2017).
In a second, more speculative model, EccD3 dimers form a channel for translocation of substrates
(Figure 6B). The large cavity found in the EccD3 dimer is striking and by structural homology, is
unlike any other membrane protein in the Protein Data Bank. In our density maps, the EccD3 dimer
cavity appears capped on the periplasmic side by a dense layer of lipids. In contrast, on the cyto-
plasmic side the cavity does not exhibit bound lipids due to the polar residues lining the lower half
of the cavity. The large cavity is of sufficient diameter to transit a folded EsxG/H dimer, however
given the strong hydrophobicity of the cavity the mechanism would not be mediated by water and
would require a novel mechanism of secretion that has not been seen in other bacterial secretion
systems. It is also possible that the cavity exists to transit a non-protein substrate such as a specific
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mycobacterial lipid. The ability to transport non-protein substrates could resolve some of the myster-
ies that remain about the relationships between ESX systems, cell wall stability, lipid content, and
nutrient acquisition (Barczak et al., 2017; Bosserman and Champion, 2017; Siegrist et al., 2014;
Tufariello et al., 2016).
As each protomer contains an EccD3 cavity, the second model, proposing translocation through
EccD3, does not require hexamerization. However, this model is also not incompatible with hexame-
rization, which would not block a substrate path through EccD3. Further, the role of the hexamer
may not be to form a central channel for substrate transit. Rather, hexamerization could serve some
other purpose. For example, it may tether functional dimers together, facilitate localization, or
increase local concentration and allosteric control of enzymatic activity (Kuriyan and Eisenberg,
2007).
Although the ESX-3 structure presented here allows for mechanistic hypotheses about the transit
of substrates across the inner-membrane, it does not provide sufficient information to allow for a
structural model of transit across the outer mycomembrane. The EccB3 periplasmic domain
(Wagner et al., 2016) has been found to have similarity to the peptidoglycan binding phage protein
A                                    B   
EccC
(motor)
EccE
EccC
(pore)
EccB
EccC
(motor)
EsxG/H
EccE
EccD EccD
EccB
ATPase 1
ATPase 2
ATPase 3
ATPase 1
ATPase 2
ATPase 3
EccE
EccD
(pore)
EccB
EccC
(motor)
EsxG/H
R
WA
R
WA
R
WA
Figure 6. Two models of the ESX-3 translocon complex. ATPase activity entails, at a minimum, oligomerization of ATPase 1 to bring the R-finger (R)
into proximity of the catalytic site, marked by the Walker A motif (WA). This requires at least 65 A˚ of movement from the position seen in the structure.
(A) The first model of ESX substrate secretion involves trimerization of the ESX-3 dimer followed by multimerization of the EccC ATPase domains into a
stack of one to four rings of ATPases (B) The second model shown through the function of a single protomer of the ESX-3 complex. Substrates are
selected by interaction with ATPase 3 of EccC and transported via the upper cytoplasmic region to the EccD cavity for secretion.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. A hexameric model of the ESX-3 dimer.
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PlyCB, which forms a ring inside the bacterial cell wall facilitating phage entrance into the cell. A
hypothesis is that EccB3 is anchored to a larger outer membrane complex, but the purification condi-
tions we have employed remove proteins required for its stabilization.
The description of ESX-3 presented here agrees in both protein composition and structure with
the work recently published by Famelis et al. Given the high sequence conservation among the ESX
systems in mycobacteria and related actinobacteria, these structures likely represent an excellent
framework for the structural modeling of the other ESX systems. Together, these structures provide
a wealth of information about protein-protein interaction interfaces and ESX complex architecture,
which can be used to guide structure-based drug design and to generate hypotheses for further
mechanistic investigations.
Materials and methods
Key resources table
Reagent type (species)
or resource
Designation
Source or
reference
Identifiers
Additional
Information
Biological sample
Mycobacterium smegmatis
mc(2)155 ATCC 700084 Wild type strain
Biological sample
Mycobacterium smegmatis
mc(2)155 with
ideR::mgd200
(KanR)
Dussurget et al., 1996,
Provided by GM Rodriguez
Biological sample
Mycobacterium smegmatis
mc(2)155,
MSMEG_0626-3C-
EGFP
This paper
Biological sample
Mycobacterium smegmatis
mc(2)155 with
ideR::mgd200
(KanR),
MSMEG_0626-3C-
EGFP
This paper
Recombinant
DNA reagent
pKM444 Murphy et al., 2018
Addgene
Plasmid #108319
Plasmid encoding for
Che9c phage RecT and
Bxb1 phage Integrase
Recombinant
DNA reagent
pKM444 - zeo This paper
Addition of zeocin
resistance cassette to
pKM444 plasmid
Recombinant
DNA reagent
pKM468-3C-
EGFP
This paper
Modified ORBIT
tagging plasmid
Sequenced-
based reagent
ORBIT targeting
oligonucleotide
This paper Oligo
5’ TGTGCGTTCCACTGGTTCCC
CGGCAACCACCTGCTGCACGTG
AGCCAGCCGGACTACCTAGGTT
TGTACCGTACACCACTGAGACC
GCGGTGGTTGACCAGACAAACC
CGCCGGATGACCCGCTTCCTGC
GCGGCTTCATGTTCGACTGAAC
CCTTCACCGAGGTCCG 3’
Antibody
Anti-GFP
stabilized antibody
preparation
Roche
Cat. #:
11814460001
Dilution 1:10000
Antibody
Anti-mouse IgG
HRP-conjugated
antibody
R&D Systems
Cat. #:
HAF007
Dilution 1:5000
Antibody
Goat anti-rabbit
IgG antibody HRP
GenScript
Cat. #:
A00098
Dilution 1:5000
Antibody
Rabbit anti-
GroEL
Sigma-Aldrich
Cat. #:
G6532-.5ML
Dilution 1:5000
Peptide,
recombinant protein
Human
Rhinovirus (HRV)
3C Protease
Thermo Scientific Pierce
Cat. #:
88946
Continued on next page
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Continued
Reagent type (species)
or resource
Designation
Source or
reference
Identifiers
Additional
Information
Commercial
assay or kit
Superose 6
Increase 10/300 GL
GE Healthcare
Cat. #:
29091596
Chemical compound,
detergent
DDM, n-Dodecyl-
b-D-Maltopyranoside
Inalco
Cat. #:
1758-1350
Chemical compound,
detergent
GDN, glyco-
diosgenin
Anatrace
Cat. #:
GDN101
Other
NativePAGE 3-
12% Bis-Tris
Protein Gels, 1.0 mm,
10-well
ThermoFisher Scientific
Cat. #:
BN1001BOX
Commercial
assay or kit
Pierce Silver
Stain Kit
Pierce
Cat. #:
PI24612
Software,
algorithm
SerialEM Mastronarde, 2005
https://bio3d.colorado.edu/
SerialEM/
Software,
algorithm
MotionCor2 Zheng et al., 2017
http://msg.ucsf.edu/em/software/
motioncor2.html
Software,
algorithm
CTFfind4 Rohou and Grigorieff, 2015
https://grigoriefflab.umassmed.edu/
ctffind4
Software,
algorithm
RELION Scheres, 2012
cam.ac.uk/relion/index.php/
Download_%26_install
Software,
algorithm
cisTEM Grant et al., 2018 https://cistem.org/
Software,
algorithm
cryosparc Punjani et al., 2017
https://cryosparc.com/docs/
reference/install/
Software,
algorithm
pyem Asarnow et al., 2019
https://github.com/
asarnow/pyem
Software,
algorithm
coot Emsley et al., 2010 https://www2.mrc-lmb.cam.
Software,
algorithm
raptorX Ka¨llberg et al., 2012 http://raptorx.uchicago.edu/
Software,
algorithm
phenix real
space refine
Afonine et al., 2018 https://www.phenix-online.
Software,
algorithm
MDFF Trabuco et al., 2009
org/documentation/reference/
refinement.html
Software,
algorithm
namdinator Kidmose et al., 2019 https://namdinator.au.dk/
Software,
algorithm
pisa Krissinel, 2015 http://www.ccp4.ac.uk/pisa/
Software,
algorithm
chimera Pettersen et al., 2004 https://www.cgl.ucsf.edu/chimera/
Software,
algorithm
chimeraX Goddard et al., 2018 https://www.cgl.ucsf.edu/chimerax/
Software,
algorithm
DALI Holm and Laakso, 2016
http://ekhidna2.biocenter.helsinki.fi/
dali/
Strain construction
Mycobacteria smegmatis mc(2)155 (wild type) and DideR cells were chromosomally tagged using the
ORBIT protocol (Figure 1—figure supplement 1). For wild type cells, the integrase and annealase
expressing plasmid was pKM444. For recombineering in the DideR strain, which already contained a
kanamycin resistance marker, we created a modified pKM444 plasmid with a zeocin resistance cas-
sette inserted at the EcoIV restriction site. The tagging plasmid was pKM468 with a 3C protease
cleavage site added before the EGFP tag. The targeting oligo had the sequence: 5’ TGTGCG
TTCCACTGGTTCCCCGGCAACCACCTGCTGCACGTGAGCCAGCCGGACTACCTAGGTTTGTACCG
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TACACCACTGAGACCGCGGTGGTTGACCAGACAAACCCGCCGGATGACCCGCTTCC
TGCGCGGCTTCATGTTCGACTGAACCCTTCACCGAGGTCCG 3’. M. smegmatis cells containing
pKM444 were grown in an overnight liquid culture and induced for annealase and integrase expres-
sion. Cells were prepared for electroporation and electroporated with the targeting oligo and tag-
ging plasmid. The transformed M. smegmatis were plated on hygromycin (wild type) or hygromycin
and kanamycin (DideR) containing 7H9 plates and incubated at 37˚ C for 3 days. Colonies were veri-
fied for insertion of the tagging plasmid into the chromosome by PCR.
Western blotting
100 mL of EccE3 tagged wild type and DideR knock out cells were grown overnight to an OD600 of
1.0–1.2. Cells were pelleted and resuspended in 1 mL of buffer (50 mM Tris-HCl pH 8.0, 150 mM
NaCl, 1% DDM) and sonicated for 30 s. Cell lysates were run on a 4–20% SDS-PAGE gel (GenScript)
and transferred to PVDF membrane (BioRad) using a BioRad Trans-Blot Turbo Transfer System. The
blot was washed with PBS and blocked in a 5% milk/PBS-T solution for 1 hr. The blot was incubated
with mouse anti-GFP monoclonal antibody (Roche) overnight. After rinsing with PBS-T, the blot was
incubated with anti-mouse IgG HRP-conjugated antibody (R&D Systems) for 2 hr. After activation
(Amersham) the blot was imaged on a BioRad ChemiDoc. The blot was stripped with stripping buffer
(ThermoFisher Scientific) as per the manufacture’s instructions, and incubated overnight with rabbit
anti-GroEL monoclonal antibody (Sigma-Aldrich). The blot was incubated with goat anti-rabbit IgG
antibody HRP (GenScript) for 2 hr, activated (Amersham), and imaged on a BioRad ChemiDoc.
Protein purification
Purification for high resolution structural determination: M. smegmatis was grown in 6 L of 7H9 sup-
plemented with 0.05% Tween 80 and 20 mg/mL kanamycin to an OD600 of ~0.8. After harvest, cells
were washed three times with PBS and frozen in liquid nitrogen before lysis with a cryogenic grinder
(SPEX SamplePrep). 24.9 g of powdered cell material was resuspended by adding 56.3 mL 50 mM
Tris-HCl pH 8.0, 150 mM NaCl, 1% DDM supplemented with 1X protease inhibitor cocktail (Sigma-
Fast) and 224 units Benzonase endonuclease. The suspension was stirred for 120 min at 4˚C. After
centrifugation for 30 min at 98,000 g, the supernatant was incubated with 1.4 mL anti-GFP-nano-
body resin for 110 min at 4˚C. The resin was transferred to a column and washed sequentially with
28 ml of wash buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl and 0.1% GDN), 14 mL of high salt
wash buffer (50 mM Tris-HCl pH 8.0, 400 mM NaCl, and 0.1% GDN), and 14 mL of wash buffer (50
mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.1% GDN). To cleave off the purification tag, the resin was
incubated o/n at 4˚C with 70 units Pierce HRV 3C protease (Thermo Scientific Pierce) in 2.8 mL wash
buffer supplemented with 0.2 mM DTT. This resin was sedimented by gentle centrifugation (300 x g
for 3 min), the supernatant collected, and the resin was subsequently washed with 1.4 mL wash
buffer. The supernatant and wash fraction were combined and concentrated using an Amicon Ultra-
4 centrifugal filter unit with a 100 kDa molecular weight cut-off. The sample was centrifuged at
16,000 g before injection on a Superose 6 10/300 column equilibrated in 50 mM Tris-HCl pH 8.0,
150 mM NaCl and 0.021% GDN. Peak fractions were concentrated using a 0.5 mL centrifugal filter
unit (Amicon, 100 kDa cut-off) to an A280 of 5.52 by Nanodrop reading in about ~30 mL . Purification
completed for examination of the void fractions was similar except: volumes were scaled for a pow-
der weight of 21.1 g. and the high salt wash was omitted.
Blue-Native polyacrylamide gel electrophoresis (BN-PAGE)
BN-PAGE experiments were carried out using the Invitrogen NativePAGE Novex Bis-Tris Gel system
as recommended by the manufacturer. Samples were prepared in a total volume of 10 mL using 0.5
mL 5% G-250 sample additive. Electrophoresis was performed at a constant voltage of 105-120 V for
2-3.5 hr at 4˚C. The gel was fixed and stained using the Pierce silver stain kit.
Cryo-EM – data acquisition
Samples were frozen for cryo-EM. Quantifoil R1.2/1.3, 400 mesh, copper grids were glow discharged
using a Solarus plasma cleaner (Gatan) with an H2/O2 mixture for 30 s. 2 mL of sample were applied
per grid and the grids were plunged into liquid ethane using a FEI Vitrobot Mark IV.
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Initially, samples were screened, and test data sets were collected on a FEI Talos Arctica 200kV
microscope equipped with a Gatan K2 Summit detector. For the initial screen of freezing conditions,
2499 movies were collected at a magnification of 36,000 with a pixel size of 1.14, and a defocus
range of  1.5 to  2.5 mm, an exposure time of 9 s, and a dose rate of 7 electrons/A˚2/second
(Table 1). Data collection for the final structure presented in the main text was collected on a FEI
Titan Krios at 300kV with a Gatan K2 Summit detector. Two imaging sessions were used. In the first
imaging session, 2705 movies were collected at a magnification of 29,000 with a pixel size of 0.82,
and a defocus of  0.4 to  1.2 mm, an exposure time of 10 s to collect 100 total frames, and a dose
rate of 8 electrons/A˚2/second (Table 1). In the second imaging session, data was collected on the
same microscope with the same detector, 4632 movies were collected at a magnification of 29,000
with a pixel size of 0.82, and a defocus range of  0.6 to  1.4 mm, an exposure time of 10 s to collect
80 total frames, and a dose rate of 6.7 electrons/A˚2/second. Data used to analyze the void, plateau,
and peak regions of the SEC profile were collected on a FEI Talos Arctica at 200kV with a Gatan K3
detector. All micrographs were collected at a magnification of 28,000 with a pixel size of 0.9, and a
defocus range of  1.5 to  2.5 mm, an exposure time of 11.7 s to collect 117 total frames at a total
dose of 58 electrons/ A˚2. For the void region, 1215 micrographs were collected.
Cryo-EM – data processing
For all data, movies were motion corrected using MotionCor2 (Zheng et al., 2017) and CTF correc-
tion was performed using CTFfind4 (Rohou and Grigorieff, 2015). For the Arctica dataset, particles
were picked using a gaussian blob in either RELION (Zivanov et al., 2018) or cisTEM (Grant et al.,
2018) and initial 2D classification was performed to remove obvious artifactual particles. Initially, a
shotgun approach was taken to generate several initial models using RELION, cisTEM, and cryosparc
(Punjani et al., 2017). Once an initial model which contained realistic low-resolution features was
generated, a user defined descent gradient was performed to improve the model with the goal of
achieving accurate secondary structure features. First, all particles selected during 2D classification
were refined in 3D against the randomly generated initial model. Second, a round of 3D classifica-
tion with four classes and default RELION settings was performed and the best class selected. Third,
the best class was refined as a single class in 3D classification with increasing Tau2_Fudge and
decreasing search angle size. The resulting EM density map had clear transmembrane helix densities
and was used as the model for a new 3D reconstruction. This reconstruction was used to back proj-
ect models for reference-based particle picking in RELION. Two rounds of 2D classification were per-
formed and the best classes selected. One round of 3D classification was performed using the
Tau2_Fudge value optimized during the previous run through (T = 12) and the best class selected. A
final 3D reconstruction of the Arctica data set yielded a map of about 4.7 A˚ resolution (Figure 1—
figure supplement 4).
After motion correction and CTF determination, the final Titan Krios dataset was processed
entirely using RELION. Particles were picked using a gaussian blob, and extracted as 4x binned par-
ticles. Two rounds of initial 2D classification were performed with T = 3 on the binned particles and
obvious artifactual particles were removed. The final reconstruction from the Arctica dataset was
used as the initial model for a 3D reconstruction of the binned particles. 3D classification with four
classes and the previously optimized Tau2_Fudge value, T = 12, was performed on the binned par-
ticles. The two best classes were selected and re-extracted without binning. A 3D reconstruction
was performed. A mask was created for the high-resolution region of the reconstruction and 3D clas-
sification without image alignment was performed focused on this region. The best class was
selected and the subsequent 4.0 A˚ reconstruction is the consensus structure for the entire complex
(Figure 1—figure supplement 5). Focused classification of each protomer, the periplasmic EccB
region, and the ATPase 1, 2, and 3 domains of EccC were performed. To perform focused classifica-
tion, the center of mass of the region of interest was determined using chimera (Pettersen et al.,
2004). Particles were recentered on this area and reextracted. Masks for the region of interest were
generated and 3D classification without image alignment was performed. The best class was
selected and used for a focused 3D reconstruction without image alignment of the region of interest.
A reconstruction was generated and density outside of the region of interest was subtracted. A final
reconstruction of the masked and density subtracted particles was then performed. This procedure
improved the resolution of the protomer i to 3.75 A˚ and protomer ii 3.83 A˚, 5.8 A˚ resolution for the
EccB3 periplasmic domain, and ~7 A˚ resolution for the EccC3 lower cytoplasmic region.
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To generate the symmetry expanded protomers based on non-point group symmetry (also known
as non-crystallographic symmetry or NCS), a transformation matrix between the two protomers was
calculated using chimera. Particles were then transformed and aligned using the subparticles.py and
star.py utilities in pyem (Asarnow et al., 2019) resulting in a particle stack with twice as many par-
ticles as the input file, each focused on protomer i or protomer ii. Density subtraction was performed
to remove density outside of the symmetry expanded protomer, and focused classification and
refinement were performed as described above. This procedure improved the resolution of the sym-
metry expanded protomer to 3.69 A˚ resolution.
Atomic model building
The cytoplasmic domain from the crystal structure of EccD1 (PDB 4KV2) was docked into the cyto-
plasmic domains of the two EccD3 molecules and the sequence was mutated. The remaining trans-
membrane domains of EccD3 and the residues 14–93 of EccB3 were built de novo in Coot
(Emsley et al., 2010) using baton building. The alpha helices of EccE3 and EccC3 were initially mod-
eled using the RaptorX (Ka¨llberg et al., 2012) homology server. The loops and strands of EccE3 and
EccC3 were built in Coot using baton building. All models were subsequently refined individually, as
a symmetry expanded protomer, left and right protomers, and as the full model using phenix real
space refine (Afonine et al., 2018), Coot, and the MDFF (Trabuco et al., 2009) server, Namdinator
(Kidmose et al., 2019; Supplementary file 1).
Low resolution modeling
The left and right protomer map, periplasmic focused refined map, and lower cytoplasmic focused
refined map were all docked into the consensus map and added together using chimera. The com-
bined map was filtered to 10 A˚ resolution to match the lowest resolution component. Homology
models for amino acids 94–516 of EccB3, the transmembrane helixes of EccC3, and 404–1268 of
EccC3 were generated using RaptorX. These models were fit into the combined map density using
the fit map to model utility in Chimera. The full model was refined using phenix.real_space_refine.
Model interpretation and display
Buried surface area between subunits was calculated by PISA (Krissinel, 2015). Atomic models for
individual proteins were compared against the PDB using the DALI server (Holm and Laakso, 2016).
Chimera and ChimeraX (Goddard et al., 2018) were used to display maps and models for figure cre-
ation. Consurf (Ashkenazy et al., 2016) was used to produce multisequence alignments and to color
structural models by homology.
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